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Background:  Incidences of serious failures in the treatment of infectious disease by antibiotics caused by the 
emergence and spread of drug resistant strains of the microorganisms/multiple drug resistant bacteria have led to 
new global search for more effective anti-infective microbial agents from natural sources. This study intends to 
examine the anti-microbial potentials of the leaves of Aspilia africana, which is employed in the treatment of wounds 
and sores by traditional medical practitioners in Nigeria. 
Objective: To evaluate the anti-microbial potentials of the isolates from leaves of Aspilia africana (Pers.) C. D. Adams 
(Aristeraceae), using isolated clinical strains of pathogens such as Staphylococcus aureus, Methicillin Resistant 
Staphylococcus aureus (MRSA), Streptococcus pyogenes, Bacillus substilis, Proteus vulgaris, Salmonella typhi, Shigella 
dysenteriae, Escherichia coli, Klebsiella pneumonia, Candida albicans and Candida stellafoidea. 
Methodology: Three compounds isolated from butanol fraction of the methanol extract of the dried powdered leaves 
of Aspilia africana through repeated silica gel column-chromatography and sephadex gel filtration, were evaluated 
for anti-microbial potentials using Agar-well diffusion method. 
Results: The isolated compounds identified as oleanolic acid, ursolic acid, and corosolic acid by 1D, 2D-NMR and 
FITR spectroscopic analyses inhibited the growth of all the pathogens with inhibition diameters ranging between 25 
– 33 mm compared with the standard drugs used. The MIC, MBC/MFC of the plant extracts ranged from between 5.00 
and 10.00 mg/mL while that of the isolated compounds ranged between 0.0125 and 0.0500mg/mL 
Discussion: From the results, we conclude that isolated compounds namely oleanolic acid, ursolic acid and corosolic 
acid are the bioactive constituents responsible for the anti-microbial activity of Aspilia africana. 
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1. Introduction 
Microbial infection is the invasion of the body by 
microorganisms that can cause disease (American 
Heritage Dictionary, 2011). Microorganisms that can 
cause infection include bacteria, fungi, protozoans, and 
viruses. One type of microbial infection that poses 
serious health risk is wound infection. Studies have 
shown that 70 percent of the deaths of patients who have 
undergone surgery are caused by surgical site infections 
(Plowman, 2000). Infected wounds are wounds in which 
bacteria or other microorganisms have colonized, 
causing a delay in wound healing and deterioration of the 
wound. The most common causative organisms 
associated with wound infections include Staphylococcus 
aureus, Methicillin-resistant Staphylococcus aureus 
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(MRSA), Streptococcus pyogenes Enterococcus faecalis 
and Pseudomonas aeruginosa (Calvin, 1998). However, 
infected wounds result when the body's immune 
defenses are overwhelmed or cannot cope with normal 
bacterial growth. The skin contains bacteria (normal 
flora) which are normally harmless if the skin is intact. 
However, the protective barrier formed by the skin is 
disrupted when there is a wound, and these normal 
floras are able to colonize the injured area. This results 
in further tissue damage and may prolong wound healing 
by promoting more inflammation. Infected wounds can 
have serious local and systemic complications. The 
infection can also affect the surrounding tissues and may 
cause a bacterial skin infection (cellulitis) or an acute or 
chronic bacterial bone infection (osteomyelitis) (Wound 
Infection, 2016). If the infection spreads to the blood 
vessels, the bacteria may spread and cause infection in 
other areas of the body. Wound infection could be 
treated by the use of antibiotics that may be applied 
directly to the wound (topical) or taken orally (systemic) 
(Ngan, 2005)). Wound microbial infection has become a 
very serious problem and health risk due to emergence 
and spread of drug resistant strains of the 
microorganisms (Kapil, 2005; Todar, 2007). This is 
further compounded by the emergence of multiple drug 
resistant bacteria (MDR) which is now a major cause of 
failure in the treatment of infectious disease by 
antibiotics (Adeola et al, 2013). The search for 
alternative natural antibiotics has become the most 
feasible way of remedying the problem of failing drugs. 
That is why plants and other natural sources have 
become targets of research now. 
One plant that is known to have many biological 
activities and is widely used in African traditional 
folkloric medicine is Aspilia africana. The leaves of 
Aspilia africana possess haemostatic, abortifacient, 
ecbolics, lactation stimulating, analgesic and sedative 
properties and is employed in the treatment of 
cutaneous, subcutaneous parasitic infection (including 
veterinary), naso-pharyngeal, skin and mucosal 
infections as well as  venereal diseases (Burkill, 1995). 
Aspilia africana is an herb, which can grow up to 2 m high 
and occurs throughout the savannah and forested zones 
of tropical Africa. It is found in all parts of Nigeria 
(Dalziel, 1955). In this research work the anti-microbial 
potentials of the methanol extract, butanol fraction and 
isolates from leaves of Aspilia africana were studied 
using selected pathogens usually implicated in wound 
infection namely: Staphylococcus aureus, Methicillin 
Resistant Staphylococcus aureus (MRSA), Streptococcus 
pyogenes, Bacillus substilis, Proteus vulgaris, Salmonella 
typhi, Shigella dysenteriae, Escherichia coli, Klebsiella 
pneumonia Candida albicans, and Candida stellafoidea. 
2. Materials and Methods 
2.1 Reagents and Analytical Equipment  
Melting points of the isolates were determined using 
Electrothermal Melting point Apparatus. The UV- 
spectrum was recorded on Pye Unicam. The silica gel for 
column chromatography (60 – 120 mesh), sephadex LH-
20 and the analytical grade reagents used were obtained 
from Sigma Aldrich. Preparative TLC plates: silica gel 60 
PF254 (Merck, Germany); visualized under UV(λmax)  254 
and 364 nm and detection with I2 and 10% ethanol H2SO4 
spray. 1H and 13C NMR, COSY, HMQC and HMBC spectra:  
JEOL AS 400,400/100 MHz, 500, 500/100 MHz) 
spectrometer (Japan), DMSO-d6 and CDCl3 as solvents 
and TMS as internal standard. Solvent peaks were at 7.26 
ppm for CDCl3 and 2.50 ppm for DMSO-d6. The chemical 
shifts were reported as δ ppm relative to TMS, Chemical 
shifs in ppm, coupling constants (J) in Hz. The samples 
were run at temperature of 25ᶱC. Mass spectra were 
obtained using HR-EI-MS: JEOL-JMS-HX-110 mass 
spectrometer; EI, source at 250ᵒ and 70 eV. FTIR (KBr) 
was recorded using 8400S Shimadzu, Japan. The 
pathogenic microorganisms obtained from the 
Department of Medical Microbiology, Ahmadu Bello 
University Teaching Hospital (ABUTH), Zaria. Mueller-
Hinton agar medium (Sigma-Aldrich, USA) was used for 
the anti-bacterial study while Sabouraud dextrose agar 
medium (Sigma-Aldrich, USA) was used for antifungal 
study and nutrient agar medium for storing and 
preserving the bacterial organisms. Ciprofloxacin 
(obtained from Trivenic Chemicals - India) and 
Fluconazole (from MDC Pharmaceuticals – India) were 
used as positive control drugs for bacterial and fungal 
strains respectively. 
2.2  Collection and Identification of Plant 
Materials 
The fresh leaves of Aspilia africana collected in Zaria, 
Northern Nigeria was identified by the taxonomist in the 
Herbarium unit of the Department of Biological Science, 
Ahmadu Bello University, Zaria. A voucher (Specimen 
No. 1146) was deposited at the Herbarium. The plant 
material was washed to remove dust and other dirt and 
dried under shade for several weeks. This dried material 
was pulverized and sieved. The weighed, powdered 
sample was stored in a labeled airtight container until 
when needed for use. 
2.3 Extraction  
The powdered leaf material (1kg) was cold-macerated in 
H2O-MEOH (30:70) for 72 h, filtered and concentrated in-
vacuo to give dark-brown gummy methanol extract 
(150.8 g, 15.08 %). The extract was dissolved in water 
and the water soluble portion was sequentially and 
exhaustively extracted with n-hexane, dichloromthane, 
ethyl acetate and n-butanol to give (after removing the 
solvent in-vacuo), n-hexane (15.0 g, 1.50%), 
dicloromethane (18.50 g, 1.85 %), ethyl acetate (10.70g, 
1.07 %) and n-butanol (35.80 g, 3.58 %) fractions 
respectively.  
2.4 Hydrolysis of the n-butanol fraction 
Acid hydrolysis (Prawat, et al, 1989) was performed on 
the n-butanol fraction, which was noted to froth 
copiously and the only fraction that showed substantial 
anti-microbial activity against the pathogens. 6 g of n-
butanol fraction was dissolved in 50 mL methanol in a 
250 mL beaker and diethyl ether was added slowly by 
the side of the beaker until the precipitation was 
complete. The precipitate was centrifuged and the solid 
residue dried to strip of the solvent completely. This was 
weighed and placed in a round-bottom flask to which 50 
mL 4 M HCl (dioxane, 1:1 H2O) was added. The set-up 
was refluxed on a water bath for 5 h at 90 ◦C. The 
resulting mixture was cooled and extracted with CHCl3. 
The CHCl3 (organic) extract was evaporated to dryness 
in-vacuo. The aqueous part was tested for the presence 
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of sugars using comparative TLC with simple 
monosaccharide sugars such as glucose, rhamnose, 
galactose, mannose and xylose. 
2.5 Isolation 
 2 g of the BUOH fraction was subjected to 
chromatographic separation on silica gel (60-120 mesh) 
column (45 x 3.5cm) and eluted with CHCl3/MEOH 
(99:1) in increasing order of polarity. This afforded 12 
fractions (HYD1-12) based on thin layer 
chromatography (TLC) analyses. Fraction HYD4 on gel 
filtration with sephadex LH-20 eluted with CHCl3 and 
MEOH afforded oleanolic acid 1 (225 mg). Fraction HYD6 
afforded ursolic acid 2 (14 mg) on recrystallization with 
methanol. Fraction HYD7 was subjected to repeated gel 
filtration using sephadex LH-20 eluted with CHCl3 and 
MEOH and finally purified with preparative thin layer 
chromatography to afford corosolic acid 3 (25mg) 
2.6 In-vitro Antimicrobial Activity Assay 
The antimicrobial activity of the isolates were 
determined using Agar-well diffusion technique (Adeniyi 
et al, 2013). 0.4 g each of the extracts and fractions was 
dissolved in 10 mL of the DMSO and further two-fold 
dilution was made to obtain concentrations of 40 
mg/mL, 20 mg/mL, 10 mg/mL, 5 mg/mL and 2.5 mg/mL. 
For the isolated compounds, 0.002 g was dissolved in 10 
mL DMSO to obtain initial stock concentration of 200 
µg/mL, which was further diluted to 100 µg/mL, 50 
µg/mL, 25 µg/mL and 12.5 µg/mL. 0.05 mg of the 
standard drugs was dissolved in 10 mL of DMSO to 
obtain a concentration of 50 µg/mL. Nutrient agar plates 
were each seeded with 0.1 ml of an overnight culture of 
each bacterial strain (equivalent to 107 CFU/mL), while 
the Sabourand dextrose agar plates were similarly 
seeded with each fungal strain. The seeded plates were 
allowed to set and then dried in the incubator at 37 °C for 
20 min. A standard cork borer of 6 mm diameter was 
used to cut uniform wells on the surface of the agar, into 
which was added 0.1 mL test solutions suspended in 
DSMO (40 mg/mL for the extract and fractions and 200 
µg/ml for the isolates). Nutrient agar plates with 
bacterial isolates were incubated at 37 °C for 24 h and 
Sabourand dextrose agar plates seeded with fungal 
strains were incubated at 25 °C for 72 h after which 
diameters of zones of inhibition were measured. This 
procedure was repeated for the standard 
chemotherapeutic agents used as positive controls 
namely Ciproflaxacin (50 ug/mL, for bacteria) and 
Fluconazole (50 ug/mL, for fungi). All the assays were 
performed in triplicate. The minimum inhibitory 
concentration (MIC) and minimum bacterialidal 
concentration (MBC)/minimum fungicidal 
concentration (MFC) tests were performed according 
procedures reported by Adeniyi et al, (2013). 
3.  Results and Discussion 
The aqueous portion of the butanol fraction indicated the 
presence of only glucose when compared with a 
reference glucose sample. Structural characterizations 
were done using a combination of 1D, 1H 13C and 2D 
experiments. Hydrogen attachments to carbon were 
identified by DEPT; 1H. H COSY and HMQC spectra. Long 
range correlations were found in the HMBC spectrum 
that also helped in assigning chemical shift to quaternary 
carbons. 1H and 13C resonance arrangements for 1, 2 and 
3 (Figure 1) are in perfect agreement with literature 
data (Seebacher et al, (2003). 
Oleanolic acid (OA, 1) was isolated as a white 
amorphous powder, mp 299-302 ᵒC.  UV(λmax):  221(c = 
0.348, CHCl3). The molecular formula C30H48O3 was 
determined on the basis of EI-MS. (calcd. 456 for 
C30H48O3). FTIR (KBr) cm-1:  3436 (OH); (2931) C-H str, 
1728 (C=C), 1389 (gem-dimethyl at C-4), 1218 (two 
methyls on qua-ternary carbon atom at C-20) and 1039 
(C-O).  1H NMR (400 MHz, DSMO-d6) ppm: δH 5.35(1H, t, 
J=4 Hz, H-12, C=C), 3.15 (1H, dd, J = 3.5 Hz, H-3, OH), 2.27 
(1H, t, J = 14 Hz), 1.15(3H, s, H-30), 0.91(3H, s, H-23), 0.93 
(3H, s H-24) 0.93 (3H, s, H-27), 0.91(3H, s, H-29), 0.79 
(3H, s, H-25) and 0.76 (3H, s, H-26). The 13C NMR, HMBC, 
HMQC and DEPT NMR showed thirty carbon atoms, 
consisted of eight quaternary, five tertiary, ten 
secondary carbons and seven methyl groups: 13C NMR 
(100 MHz, DSMO-d6) ppm: δC 178.02(C-28), 144.12(C-
13), 122.24 (C-12), 77.78 (C-3) 55.39 (C-5), 47.70 (C-9), 
46.05 (C-19), 45.99 (C-17), 41.70 (C-8), 41.70 (C-14) 
41.43 (C-18), 39.35(C-1), 38.69 (C-21), 38.51 (C-4), 
37.01 (C-10), 33.64 (C-7), 32.84 (C-20), 32.55 (C-29), 
30.51 (C-15), 27.89 (C-22), 27.63 (C-2), 27.29 (C-23), 
25.45 (C-30), 23.32 (C-11), 23.07 (C-16), 22.95 (C-17), 
18.33 (C-6), 16.80 (C-25), 15.50 (C-26) and 14.98 (C-24). 
Ursolic Acid (UA, 2) was obtained as a white amorphous 
powder (14 mg), mp 284-287℃, Rf : 0.70 (CHCl3–MeOH, 
9:1). UV(λmax):  222 (c = 0.647, CHCl3). The molecular 
formula C30H48O3 was determined on the basis of EI-MS. 
(calcd. 456 for C30H48O3). FTIR (KBr) cm-1: 3450 (OH), 
2931(CH stretch), 1644.37 (C=C), 1373 (gem-dimethyl at 
C-4) and 1045 (C-O). The NMR resonances are similar to 
those of oleanolic acid. 1H NMR (400 MHz,  DSMO-d6) 
ppm: δH 5.58 (1H, brs, H-12, C=C) 4.08 (1H, dd, J=6.2, 11.0 
Hz, H-3), 1.45(1H, H-18), 1.28 (3H, s, H-27), 1.03 (3H, d, 
J= 4Hz, H-29), 0.99 (3H, s, H-23), 0.99 (3H, s, H-24), 0.98 
(3H, d, J=6.2 Hz, H-30), 0.96 (3H, s, H-25) and 0.93 (3H, s, 
H-26). 13C NMR spectrum showed 30 signals, consisted 
of seven quaternary carbons, seven tertiary, nine 
secondary and seven methyl groups.  13C NMR (100 MHz, 
CD3OD) ppm:  δC 173.69 (C-28), 145.19 (C-13), 121.65 (C-
12), 80.58 (C-3), 55.26 (C-5), 47.55 (C-18), 47.55 (C-9), 
47.24 (C-17), 41.70 (C-14), 39.81 (C-8), 39.62 (C-20), 
39.62(C-19), 39.38 (C-1), 38.25(C-4), 37.83 (C-10), 37.15 
(C-22), 33.34 (C-7), 30.06 (C-21), 29.18 (C-15), 28.75 (C-
23), 28.40 (C-2), 25.96 (C-27), 24.28 (C-16), 23.69 (C-
11), 21.28 (C-30), 18.27 (C-6), 17.51 (C-26), 16.78 (C-
29), 16.58 (C-24) and 16.36 (C-25). 
Corosolic Acid (CA, 3) crystallized in MEOH as a white 
amorphous powder (25 mg), mp 238-242 ℃; Rf: 0.79 
(CHCl3–MeOH, 9:1). UV (λmax):  262 (c = 2.310, CHCl3). The 
molecular formula C30H48O4 was determined on the basis 
of EI-MS. (calcd. 472 for C30H48O4). FTIR (KBr) cm-1: 3472 
(OH), 2930 (CH stretch), 1725 (C=C), 1389 (gem-
dimethyl at C-4), 1167 and (tert. alc. C-O str.). 1H-NMR 
(500 MHz, CDCl3)  ppm:  δH  5.43 (1H, t, J = 4.0 Hz, H-12, 
C=C ), 4.45 (1H, dd, J = 4.0, 12.0 Hz, H-2), 4.02 (1H, d, J = 
10.1 Hz, H-3) and 3.09 (dd, J = 14.2, 4.0  Hz, H-18), five 
singlet methyls at δH 1.01 (H-23), 1.005, H-24), 1.021 (H-
25), 1.031, (H-26), 0.965, (H-27), and two doublet 
methyls at δH 0.996  (J = 6.7 Hz, C-29) and 0.97, J = 6.8 Hz, 
H-30). 13C NMR (100 MHz, CDCl3) ppm:  δC 173.749 (C-
28), 145.00 (C-13), 121.658 (C-12), 80.622 (C-3), 64.418 
(C-2), 64.418 (C-18), 55.260 (C-5), 47.556 (C-9), 47.555 
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(C-17), 47.242 (C-20), 46.795 (C-1), 41.725 (C-14), 
40.849 (C-8), 39.818 (C-4), 39.374 (C-19), 38.258 (C-10), 
34.873 (C-7), 34.434 (C-22), 29.696 (C-21), 29.175 (C-
15),  28.394 (C-23), 24.792 (C-30), 23.792 (C-27), 23.607 
(C-11), 22.687 (C-16), 19.026 (C-26), 18.268 (C-6), 
16.992 (C-25), 16.811 (C-24), 16.772 (C-29). 
OA and UA are isomeric triterpenic acids and always 
simultaneously exist in the same plant (Liu, 1995; Xu et 
al, 2012). Their spectroscopic data are similar depicting 
their structural similarities with the only difference 
being the positions of the methyl groups of C-29 and C-
30. In oleanolic  acid, the two groups are “geminally” 
attached to C-20 and this is a feature of β-amyrins to 
which oleanolic acid belong, thus making C-19 to have 
two protons attached to it. This is clearly established by 
appearance of a triplet observed at 2.27 ppm with a J 
value of 14.0 Hz in NMR spectra indicating coupling 
between a single proton at C-18 and two protons at C-19 
as deduced from 1H 1H COSY and HMQC spectra. This 
triplet only appears if the compound is of theβ-type 
triterpene -oleanane ; where only protons (two protons) 
are attached to C-19 (Bhatt, 2011). This is confirmed by 
FTIR absorption at 1218 cm-1 (two methyls on qua-
ternary carbon atom- indicating the two methyl groups 
on C-20 which distinguishes it from the isomer (ursolic 
acid, Fig. 1), which has one methyl group at this position 
(Mann et al, 2012). The α –type orientation in compound 
2 was established by appearance of a doublet at δH 2.35 
(br-d, J = 10.2 Hz); assigned to H-18, (a doublet appears 
here because the two groups attached to C-19 are 
hydrogen and methyl and the coupling between a single 
proton at C-18 and C-19 would produce a doublet (Bhatt, 
2011). The FTIR spectrum of compound 2 shows that the 
peak at 1218 cm-1 is absent; showing that two methyls 
on qua-ternary carbon (C-20) atom- is absent confirming 
that 2 is an ursane triterpene. Compound 3 (Corosolic 
acid) is a derivative of ursolic acid having additional –OH 
group at C-2. The NMR data for compound 3 are similar 
to those of compound 2 (ursolic acid) except the 
chemical shift at δC 64.418 ppm which is assigned to C-2 
because of the second OH in the molecule. In comparison, 
the 13C NMR data of compound 3 showed a good 
agreement with reported data of corosolic acid (Park et 
al, 2002; Lee and Juang, 2005). 
 
Figure 1: Structures of Oleanolic acid (OA, 1), Ursolic Acid (UA, 2) and Corosolic Acid (CA, 3)  
 
Table 1: Susceptibility of bacterial and fungal strains to the isolates, extracts and control drugs 
Test Organism 
Zone of inhibition (mm) 
OA UA CA ME BE CP FL 
Staphylococcus aureus 31.21±0.20 32.60±0.33 30.21±0.50 20.00±.0.3 24.10±0.1 37.00±0.0 0 
MRSA 30.7±0.210 32.30±1.55 28.02±0.10 21.50±0.3 22.00±0.0 32.00±0.1 0 
Streptococcus pyogenes 29.02±0.15 26.11±0.31 25.02±0.10 0.00 0.00 38.00±0.2 0 
Bacillus cereus 30.25±0.20 27.10±0.70 26.25±0.20 20.10±0.1 27.11±0.5 40.30±0.3 0 
Proteus vulgaris 25.22±0.80 30.55±0.67 29.15±0.80 0.00 0.00 0.00 0 
Salmonella  typhi 28.30±0.40 31.01±2.11 25.30±0.30 21.00±0.0 24.24±0.2 32.20±0.5 0 
Shingella dysenteriae 26.10±0.10 27.06±0.89 27.10±2.50 0.00 0.00 39.30±0.4 0 
Klesiella pneumonae 25.20±0.10 26.32±0.10 27.20±0.80 22.32±0.1 25.20±0.2 30.32±0.8 0 
Escherchia  coli 31.50±0.40 28.06±1.40 26.20±3.40 22.06±1.4 25.33±0.5 42.36±0.7 0 
Candida  albicans 26.02±0.20 25.30±0.50 25.08±0.70 20.30±0.5 22.10±0.1 0.00 40.2±0.2 
Candida  stellatoidea 27.22±0.20 25.40±2.21 27.25±0.90 10.0±0.2 12.0±0.2 0.00 34.1±0.2 
Values are mean ± standard error of mean, diameter of cork borer = 6 mm 
OA: Oleanolic acid; UA: Ursolic acid; CA: Corosolic acid; ME: Methanol extract; BE n-Butanol fraction; CP: Ciproflaxacin; FL: Fluconazole. 
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Table 2: MIC and MBC of the isolates, extracts, and the control drugs on the susceptible bacteria and fungi strains 
Organism  
OA UA CA ME BF Control* 
mg/mL mg/mL mg/mL mg/mL mg/mL mg/mL 
Staphylococcus aureus MIC 
MBC 
0.0250 
0.0500 
0.0125 
0.0125 
0.0250 
0.0500 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
MRSA MIC 
MBC 
0.0250 
0.0250 
0.0125 
0.0125 
0.0500 
0.0500 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
Bacillus cereus MIC 
MBC 
0.0250 
0.0250 
0.0125 
0.0125 
0.0250 
0.0250 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
Proteus vulgaris MIC 
MBC 
0.0500 
0.0500 
0.0125 
0.0125 
0.0250 
0.0250 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
Pseudomenas fluorescence MIC 
MBC 
0.0250 
0.0250 
0.0500 
0.0500 
0.0250 
0.0250 
10.00 
10.00 
5.00 
5.00 
0.003125 
0.003125 
Salmonella typhi MIC 
MBC 
0.0250 
0.0250 
0.0125 
0.0125 
0.0250 
0.0250 
10.00 
10.00 
5.00 
5.00 
0.003125 
0.003125 
Shingella dysenteriae MIC 
MBC 
0.0250 
0.0250 
0.0125 
0.0125 
0.0250 
0.0250 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
Klebsiella Pneumonae MIC 
MBC 
0.0500 
0.0500 
0.0125 
0.0125 
0.0250 
0.0500 
5.00 
5.00 
5.00 
5.00 
0.003125 
0.003125 
Escherchia coli MIC 
MBC 
0.0500 
0.0500 
0.0125 
0.0125 
0.0250 
0.0500 
10.00 
10.00 
10.00 
10.00 
0.003125 
0.003125 
Candida albicans MIC 
MFC 
0.0500 
0.0500 
0.0125 
0.0125 
0.0500 
0.0500 
0.00 
0.00 
10.00 
10.00 
0.003125 
0.003125 
Candida stellatoidea MIC 
MFC  
0.0250 
0.0250 
0.0125 
0.0125 
0.0250 
0.0250 
0.00 
0.00 
0.00 
0.00 
0.003125 
0.003125 
OA: Oleanolic acid, UA: Ursolic acid, CA: Corosolic acid, ME: Methanol extract, BF: Butanol fraction,  
*Ciproflaxcin for Bacteria, Fluconazole for fungi. (0.001mg/mL =1.000 µg/mL) 
The isolates obtained from the leaves Aspilia africana 
demonstrated broad-spectrum anti-microbial activities 
as shown in Table 1. These microorganisms were 
selected based on their established identity as wound 
pathogens and are always implicated in wound sepsis 
and sores (Hugo and Russel, 1983). The results show that 
all the pathogens including highly resistant bacterial 
strain like MRSA, C. albicans and C. stellatoidea were 
highly susceptible, with  diameter of zones of inhibition 
ranging between 25.00 and 32.00 mm (Table 1) (Ibeh 
and Uraih 2003). The anti-bacterial and anti-fungal 
activities of the plant extracts and isolated compounds 
compared favourably with that of the standard drugs 
(ciprofloxacin and fluconazole). The MIC of the plant 
extracts ranged between 5.00 and 10 mg/mL, while that 
of the isolated compounds ranged between 0.0125 and 
0.0500 mg/mL. The MIC and MBC/MFC of the plant 
extracts and isolates were obtained as shown in Table 2. 
The LD50 of the methanol extract of the leaves was 
obtained from acute toxicity test as 4472.14 mg/kg. 
There are several reports of significant antimicrobial 
activity by OA, UA and CA isolated from diverse plants. 
Studies have shown that UA and OA are the specific 
agents responsible for the anti-mycobacterial activity of 
Lantana hispida and Chamaedora tepejilote (tropical 
plants from Mexico used in folklore medicine to treat 
tuberculosis and respiratory diseases).  
The study shows, UA and OA isolated from these plants 
to have the in vitro anti-mycobacterial activity against 
the reference drug sensitive Mycobacterium tuberculosis 
strain H37Rv, mono-resistant H37Rv strains, several 
MDR clinical isolates and a group of non-tuberculous 
mycobacteria with MIC ranging from 12.5 to 100 μg/mL. 
The report also shows that UA and OA which are isomers, 
when combined produced in vitro intracellular and in 
vivo synergistic effects with lower MIC values (Jiménez-
Arellanes et al, 2013).   
In another study by Kim et al (2012), the minimum 
bacterial concentrations (MBC) values of UA and OA 
against 19 MRSA strains showed broad ranges; 4 to 32 
μg/ml and 16 to >256 μg/mL, and minimum inhibitory 
concentrations (MIC) values of 4 – 8 μg/mL and 16 to 32 
μg/mL respectively. This compares favourably with 
results obtained in this present study which range 
between 12.5 and 25 μg/ml for both MBC and MIC for 
MRSA. Rivero et al (2009) determined MIC for OA which 
ranged from 212 to 848 μg/mL for, Klebsiella 
pneumoniae, Staphylococcus aureus, Escherichia coli, 
Pseudomonas aeruginosa, Salmonella typhi, Streptococcus 
pneumonia; these values are far above the doses 
observed in this study. This indicates that the microbial 
activity of these triterpenic acids is not much higher than 
traditionally used antimicrobials, but the study on them 
is worthy because they are natural source products, and 
no resistance is found yet (Wolska et al, 2010). They are 
therefore potentially excellent agents for eradicating the 
growth of micro-organisms. 
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4. Conclusion 
The findings of this study indicate that the bioactive 
isolates are very effective and can tackle the problem of 
resistance of the virulent microorganisms. It can be 
concluded that, these bioactive constituents are 
responsible for anti-microbial activity of the leaves of 
this plant. The isolation of  oleanolic acid, ursolic acid and 
corosolic acid (pentacyclic triterpenic compounds) with 
well-defined therapeutic uses such anti-microbial, 
hepatoprotective anti-hyperglycaemic and anti-
inflamatory from A. aficana lends credence to the 
traditional use of the plant in the treatment of these 
disease conditions  especially those of microbial origins. 
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